Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.81 Analyst target: $12.00 Upside: 149.48%
Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. The company is headquartered in Hackensack, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.